Skip to main content
. 2011 Nov 28;30(6):593–599. doi: 10.1200/JCO.2010.33.8889

Fig 2.

Fig 2.

(A) Kaplan-Meier overall survival curves by human epidermal growth factor receptor 2 (HER2) status for patients with distant metastases. (B) Kaplan-Meier overall survival curves by combinations of trastuzumab and HER2 status for patients with distant metastases. HR, hazard ratio.